Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 20;19(1):79.
doi: 10.1186/s13023-024-03083-3.

The spectrum of neurological presentation in individuals affected by TBL1XR1 gene defects

Affiliations

The spectrum of neurological presentation in individuals affected by TBL1XR1 gene defects

Amanda Nagy et al. Orphanet J Rare Dis. .

Abstract

Background: TBL1XR1 encodes a F-box-like/WD40 repeat-containing protein that plays a role in transcription mediated by nuclear receptors and is a known genetic cause of neurodevelopmental disease of childhood (OMIM# 608628). Yet the developmental trajectory and progression of neurologic symptoms over time remains poorly understood.

Methods: We developed and distributed a survey to two closed Facebook groups devoted to families of patients with TBL1XR1-related disorder. The survey consisted of 14 subsections focused upon the developmental trajectories of cognitive, behavioral, motor, and other neurological abnormalities. Data were collected and managed using REDCap electronic data capture tools.

Results: Caregivers of 41 patients with a TBL1XR1-related disorder completed the cross-sectional survey. All reported variants affecting a single amino acid, including missense mutations and in-frame deletions, were found in the WD40 repeat regions of Tbl1xr1. These are domains considered important for protein-protein interactions that may plausibly underlie disease pathology. The majority of patients were diagnosed with a neurologic condition before they received their genetic diagnosis. Language appeared most significantly affected with only a minority of the cohort achieving more advanced milestones in this domain.

Conclusion: TBL1XR1-related disorder encompasses a spectrum of clinical presentations, marked by early developmental delay ranging in severity, with a subset of patients experiencing developmental regression in later childhood.

Keywords: Autism; Behavior; Epilepsy; Genetic diseases; Intellectual disability; Pierpont syndrome; TBL1XR1.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Genetic variants reported by survey participants (N = 41). A Types of genetic variants reported in patients diagnosed with Pierpont Syndrome (n = 18) compared to those without a Pierpont diagnosis (n = 23). Genetic information was not provided for 9 subjects. B Location of missense variants (red) and in-frame deletions (blue) in the TBL1XR1 gene reported by survey participants. Recurrent sites are denoted by increased size of the “lollipop” circle. All missense variants (n = 20) and in-frame deletions (n = 3) reported by survey participants occurred in WD40 repeat regions
Fig. 2
Fig. 2
Developmental trajectory in patients with TBL1XR1-related disorder.. The age of reported developmental milestone acquisition is shown as a range with a vertical bar denoting the median
Fig. 3
Fig. 3
Acquisition of gross motor skills in patients with TBL1XR1-related disorder. Cumulative incidence curves are shown representing the age of acquisition of major motor milestones, with red lines denoting 95% confidence intervals. Respondents were excluded if the skill was attained but the age of acquisition was not reported or if it was unable to be determined whether the skill was obtained
Fig. 4
Fig. 4
Gain and loss of language skills in patients with TBL1XR1-related disorder. Cumulative incidence curves are shown representing the age of acquisition and loss of major language milestones, with red lines denoting 95% confidence intervals. Respondents were excluded if the skill was attained or regression occurred but the age of acquisition or regression was not reported. Respondents were also excluded if it was unable to be determined whether the skill was obtained or whether regression occurred
Fig. 5
Fig. 5
The presence of seizures and association with developmental regression in patients with TBL1XR1-related disorder. A Cumulative incidence curve is shown representing the onset of seizures in 13 patients by age, with red lines denoting the 95% confidence interval. Respondents were excluded if age at the onset of seizures was not reported. B The presence of regression is shown by developmental domain, with those reporting no regression indicated by ‘none’. Groups are further divided by the presence or absence of seizures

References

    1. Rosello R, Martinez-Raga J, Tomas JM, Mira A, Cortese S. Cognitive and behavioral profiles in children with autism spectrum disorder with and without attention-deficit/hyperactivity disorder. Child Adolesc Ment Health. 2022 doi: 10.1111/camh.12562. - DOI - PubMed
    1. Hoytema van Konijnenburg EMM, Wortmann SB, Koelewijn MJ, Tseng LA, Houben R, Stöckler-Ipsiroglu S, et al. Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app. Orphanet J Rare Dis. 2021;16:170. doi: 10.1186/s13023-021-01727-2. - DOI - PMC - PubMed
    1. EuroEPINOMICS RES Consortium. Heyne HO, Singh T, Stamberger H, AbouJamra R, Caglayan H, et al. De novo variants in neurodevelopmental disorders with epilepsy. Nat Genet. 2018;50(7):1048–1053. doi: 10.1038/s41588-018-0143-7. - DOI - PubMed
    1. Ellis K, Moss J, Stefanidou C, Oliver C, Apperly I. The development of early social cognitive skills in neurogenetic syndromes associated with autism: Cornelia de Lange, fragile X and Rubinstein–Taybi syndromes. Orphanet J Rare Dis. 2021;16:488. doi: 10.1186/s13023-021-02117-4. - DOI - PMC - PubMed
    1. Riggs ER, Bingaman TI, Barry CA, Behlmann A, Bluske K, Bostwick B, et al. Clinical validity assessment of genes frequently tested on intellectual disability/autism sequencing panels. Genet Med. 2022;S1098360022007560. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources